{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:46:38Z","timestamp":1785818798135,"version":"3.56.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Serum ferritin (SF) is a routine biomarker reflecting iron status and systemic inflammation. We performed a systematic review and meta-analysis to validate the prognostic value of circulating SF for overall survival (OS) in adult patients with malignant tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental design<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, Cochrane Library, the Chinese databases CNKI and Wanfang from inception to December 31, 2025, for retrospective cohort studies reporting the association between SF levels and overall survival (OS) in cancer patients. Two reviewers independently screened studies, extracted data, and assessed quality via the Newcastle-Ottawa Scale (NOS). Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated, with prespecified subgroup, sensitivity, and publication bias analyses. This study was prospectively registered in PROSPERO (CRD420251271950).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ten moderate-to-high quality studies (3,083 patients) were included. Elevated SF was significantly associated with increased mortality risk (pooled HR\u00a0=\u00a01.78, 95% CI: 1.55\u20132.05,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001), with consistent effects across all prespecified subgroups (all\n                      <jats:italic>P<\/jats:italic>\n                      for interaction &amp;gt; 0.05). We preliminarily identified a 300\u2013500 ng\/mL SF threshold as the high-risk range for adverse outcomes (exploratory analysis, 2 studies, HR\u00a0=\u00a02.26). Publication bias adjustment did not alter the core conclusion (adjusted HR\u00a0=\u00a01.70).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher SF correlates with worse OS in adult patients with both hematologic malignancies and solid tumors. Our data only offers preliminary reference for risk stratification, and we cannot recommend routine clinical application right now. Larger prospective trials are needed to verify the ferritin concentration cut-off and different predictive values of pre- and post-treatment testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , identifier CRD420251271950.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1892172","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:27:07Z","timestamp":1785817627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum ferritin as a non-invasive prognostic biomarker in cancer: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Xuewen","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/mtomcs\/mfab021","article-title":"Chemistry and biology of ferritin","volume":"13","author":"Plays","year":"2021","journal-title":"Metallomics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2016.0112","article-title":"High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis","volume":"30","author":"Oikonomou","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2017.3.16110","article-title":"High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer","volume":"38","author":"Hong","year":"2017","journal-title":"Saudi Med J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1053\/j.gastro.2011.01.053","article-title":"Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C","volume":"140","author":"Lambrecht","year":"2011","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12618","article-title":"Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation","volume":"29","author":"Facciorusso","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10549-010-0849-4","article-title":"Role of ferritin alterations in human breast cancer cells","volume":"126","author":"Shpyleva","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"B9","article-title":"The association between serum ferritin with colorectal cancer","volume":"8","author":"Feng","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2019.05.013","article-title":"Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy","volume":"29","author":"Wu","year":"2019","journal-title":"Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7150\/jca.26853","article-title":"Prognostic value of ferritin-to-hemoglobin ratio in patients with advanced non-small-cell lung cancer","volume":"10","author":"Lee","year":"2019","journal-title":"J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02816-6","article-title":"Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma","volume":"111","author":"Kim","year":"2020","journal-title":"Int J Hematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14977","article-title":"Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4103\/2319-4170.132888","article-title":"Serum levels of ferritin, copper, and zinc in patients with oral cancer","volume":"37","author":"Baharvand","year":"2014","journal-title":"BioMed J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12592","article-title":"Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma","volume":"39","author":"Koyama","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2015.05.001","article-title":"Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics","volume":"39","author":"Lebon","year":"2015","journal-title":"Leuk Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i33.12230","article-title":"Prognostic role of pretreatment serum ferritin concentration in lung cancer patients: a meta-analysis","volume":"10","author":"Gao","year":"2022","journal-title":"World J Clin cases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PloS Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B20","unstructured":"PRISMA Statement"},{"key":"B21","unstructured":"The Newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses\n          \n          \n            \n              Wells\n              GA\n            \n            \n              Shea\n              B\n            \n            \n              O\u2019Connell\n              D\n            \n            \n              Peterson\n              J\n            \n            \n              Welch\n              V\n            \n            \n              Losos\n              M\n            \n          \n          \n          2010"},{"key":"B22","article-title":"Cochrane handbook for systematic reviews of interventions version 6.2","author":"Higgins","year":"2021","journal-title":"Cochrane Collaboration"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2009.24.4.368","article-title":"Elevation of serum ferritin is associated with the outcome of patients with newly diagnosed multiple myeloma","volume":"24","author":"Song","year":"2009","journal-title":"Korean J Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/10428194.2018.1461860","article-title":"AML: High serum ferritin at initial diagnosis has a negative impact on long-term survival","volume":"60","author":"Ihlow","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1038\/s41598-024-54627-3","article-title":"Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1048-3","article-title":"Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome","volume":"95","author":"Kikuchi","year":"2012","journal-title":"Int J Hematol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71127","article-title":"Impact of pre-treatment serum ferritin on response and survival in myelodysplastic syndromes treated with azacytidine: a multivariate analysis","volume":"14","author":"Carrasco","year":"2025","journal-title":"Cancer Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02710-1","article-title":"Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes","volume":"110","author":"Kawabata","year":"2019","journal-title":"Int J Hematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.891025","article-title":"Ferritin as prognostic marker in multiple myeloma patients undergoing autologous transplantation","volume":"55","author":"Strasser-Weippl","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31384","article-title":"Iron status in relation to cancer risk and mortality: findings from a population-based prospective study","volume":"143","author":"Pacheco","year":"2018","journal-title":"Int J Cancer"},{"key":"B31","article-title":"Preoperative serum ferritin, albumin, and ferritin-to-albumin ratio in patients with hepatocellular carcinoma after hepatectomy","volume":"26","author":"Gu","year":"2022","journal-title":"J Pract Clin Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3877\/cma.j.issn.2095-3232.2021.03.018","article-title":"Correlation analysis between serum ferritin and prognosis of primary liver cancer","volume":"10","author":"Zhao","year":"2021","journal-title":"Chin J Hepat Surg (Electronic Edition)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2317-y","article-title":"Clinical significance of serum ferritin in elderly patients with primary lung carcinoma","volume":"35","author":"Ji","year":"2014","journal-title":"Tumour Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051379","article-title":"Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy","volume":"7","author":"Alkhateeb","year":"2012","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040801","article-title":"Meta-analysis of the prognostic value of pretreatment serum ferritin in hepatobiliary and pancreas (HBP) cancers","volume":"11","author":"Lin","year":"2021","journal-title":"BMJ Open"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/172460080602100407","article-title":"Serum ferritin in colorectal cancer patients and its prognostic evaluation","volume":"21","author":"Lorenzi","year":"2006","journal-title":"Int J Biol Markers"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2285367","article-title":"Serum ferritin level is an effective prognostic factor for lung cancer immunotherapy","volume":"24","author":"Wang","year":"2023","journal-title":"Cancer Biol Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.186","article-title":"Serum ferritin predicted prognosis in patients with locally advanced pancreatic cancer","volume":"11","author":"Wang","year":"2015","journal-title":"Future Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7150\/jca.14797","article-title":"Serum ferritin as a prognostic biomarker for survival in relapsed or refractory metastatic colorectal cancer","volume":"7","author":"Lee","year":"2016","journal-title":"J Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1179\/135100002125000596","article-title":"Iron and carcinogenesis: from Fenton reaction to target genes","volume":"7","author":"Toyokuni","year":"2002","journal-title":"Redox Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2013.07.002","article-title":"The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis","volume":"1836","author":"Alkhateeb","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","journal-title":"Int Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2025.12129","article-title":"Serum ferritin as a prognostic biomarker in CAR-T therapy for multiple myeloma: a meta-analysis","volume":"25","author":"Cheng","year":"2025","journal-title":"Biomol BioMed"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202111_27091","article-title":"Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer","volume":"25","author":"Demir","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1892172\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:27:10Z","timestamp":1785817630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1892172\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":44,"alternative-id":["10.3389\/fonc.2026.1892172"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1892172","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"1892172"}}